Immunization with a Nontoxic/Nonfibrillar Amyloid-β Homologous Peptide Reduces Alzheimer’s Disease-Associated Pathology in Transgenic Mice

Documenti analoghi

• Blocking the Apolipoprotein E/Amyloid β Interaction in Triple Transgenic Mice Ameliorates Alzheimer’s Disease Related Amyloid β and Tau Pathology
  di: Liu, Shan, et al.
  Pubblicazione: (2013)
• Amyloid β and Tau Alzheimer’s disease related pathology is reduced by Toll-like receptor 9 stimulation
  di: Scholtzova, Henrieta, et al.
  Pubblicazione: (2014)
• Memantine Leads to Behavioral Improvement and Amyloid Reduction in Alzheimer’s-Disease-Model Transgenic Mice Shown as by Micromagnetic Resonance Imaging
  di: Scholtzova, Henrieta, et al.
  Pubblicazione: (2008)
• Blocking the apolipoprotein E/amyloid-β interaction as a potential therapeutic approach for Alzheimer's disease
  di: Sadowski, Martin J., et al.
  Pubblicazione: (2006)
• Vaccination of Alzheimer’s model mice with Aβ derivative in alum adjuvant reduces Aβ burden without microhemorrhages
  di: Asuni, Ayodeji A., et al.
  Pubblicazione: (2006)